GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Shares Buyback Ratio %

Immunoclin (Immunoclin) Shares Buyback Ratio % : 0.00 (As of May. 23, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Immunoclin's current shares buyback ratio was 0.00%.

Immunoclin Shares Buyback Ratio % Historical Data

The historical data trend for Immunoclin's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Shares Buyback Ratio % Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Shares Buyback Ratio %
- -6.96 -394.37

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.55 - -155.01 -0.23 -8.87

Immunoclin Shares Buyback Ratio % Calculation

Immunoclin's Shares Buyback Ratio for the fiscal year that ended in Jan. 2014 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jan. 2013 ) - Shares Outstanding (EOP) (A: Jan. 2014 )) / Shares Outstanding (EOP) (A: Jan. 2013 )
=(5.36102 - 26.5035) / 5.36102
=-394.37%

Immunoclin's Shares Buyback Ratio for the quarter that ended in Oct. 2014 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jul. 2014 ) - Shares Outstanding (EOP) (A: Oct. 2014 )) / Shares Outstanding (EOP) (A: Jul. 2014 )
=(26.4811 - 28.8312) / 26.4811
=-8.87%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunoclin Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Immunoclin's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Shares Buyback Ratio %
Comparable Companies
BOM:506128 ASX:ATX OSTO:ANNX IMUN ASX:FIJ ASX:FTT ATRX TSXV:THRM WAR:BLR FNAM ASX:NC6 XCNQ:VP ENLV ASX:RAC VODG TSXV:MFS OSTO:A1M XSAT:CLINE B ASX:MEB XCNQ:LILY
Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Website
http://www.immunoclin.com
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines